Measles, measles vaccination, and risk of subacute sclerosing panencephalitis (SSPE)
- 1 December 1983
- journal article
- research article
- Published by Wolters Kluwer Health in Neurology
- Vol. 33 (12) , 1588
- https://doi.org/10.1212/wnl.33.12.1588
Abstract
Between the years 1968 and 1979, 87 cases of subacute sclerosing panencephalitis (SSPE) appeared among the Israeli-born population. The incidence of SSPE dropped sharply in 1977, 10 years (the median age at onset of SSPE) after introduction of mass antimeasles vaccination, and remained low in 1978 and 1979. Most of the SSPE cases reported measles at an age significantly younger than that of the general population. This pattern did not change after introduction of antimeasles vaccination. Incidence was significantly lower (p < 10−9) in the vaccinated population than in the unvaccinated population. Occurrence of SSPE in some children who were vaccinated against measles could be explained by incomplete vaccine efficacy, or by older age at vaccination, which allows the possibility of prior exposure to measles. There was no indication that measles vaccine can induce SSPE.This publication has 4 references indexed in Scilit:
- MEASLES-VACCINE EFFICACY IN CHILDREN PREVIOUSLY VACCINATED AT 12 MONTHS OF AGE1978
- Epidemiologic Studies of Measles, Measles Vaccine, and Subacute Sclerosing PanencephalitisPediatrics, 1977
- Present status of measles and rubella immunization in the United States: A medical progress reportThe Journal of Pediatrics, 1977
- Cellular inclusions in cerebral lesions of lethargic encephalitis1933